#Genotyping
2025 Annual Australian Measles and Rubella Genotyping Surveillance Program Report https://pubmed.ncbi.nlm.nih.gov/43035022/
November 16, 2026 at 11:21 AM
CannSelect genome-wide genotyping platform developed for Cannabis sativa breeding research
www.mmjdaily.com/article/9892...
CannSelect genome-wide genotyping platform developed for Cannabis sativa breeding research
Researchers at Cornell University and collaborating institutions have published CannSelect, a genome-wide target-enrichment genotyping platform for Cannabis sativa, in PLOS ONE on November…
www.mmjdaily.com
November 15, 2026 at 2:22 PM
Dr Jean Kok, a postdoctoral researcher in the Robling Lab at Indiana University School of Medicine is investigating the molecular mechanisms underpinning muscle–bone crosstalk using mouse models using liquid handling pipettes from INTEGRA Biosciences. buff.ly/wtWyEC7
Streamlining genotyping workflows for muscle-bone research
www.labroots.com
November 17, 2026 at 6:13 PM
Dr Jean Kok, a postdoctoral researcher in the Robling Lab at Indiana University School of Medicine is investigating the molecular mechanisms underpinning muscle–bone crosstalk using mouse models using liquid handling pipettes from INTEGRA Biosciences. buff.ly/wtWyEC7
Streamlining genotyping workflows for muscle-bone research
www.labroots.com
November 17, 2026 at 6:13 PM
Integrated genotyping, annotation and epigenetic characterization of transposable elements with GraffiTE https://www.biorxiv.org/content/10.64898/2026.11.06.764993v1
November 9, 2026 at 9:46 PM
Dr Jean Kok, a postdoctoral researcher in the Robling Lab at Indiana University School of Medicine is investigating the molecular mechanisms underpinning muscle–bone crosstalk using mouse models using liquid handling pipettes from INTEGRA Biosciences. buff.ly/wtWyEC7
Streamlining genotyping workflows for muscle-bone research
www.labroots.com
November 17, 2026 at 6:13 PM
Dr Jean Kok, a postdoctoral researcher in the Robling Lab at Indiana University School of Medicine is investigating the molecular mechanisms underpinning muscle–bone crosstalk using mouse models using liquid handling pipettes from INTEGRA Biosciences. buff.ly/wtWyEC7
Streamlining genotyping workflows for muscle-bone research
www.labroots.com
November 17, 2026 at 6:13 PM
Dr Jean Kok, a postdoctoral researcher in the Robling Lab at Indiana University School of Medicine is investigating the molecular mechanisms underpinning muscle–bone crosstalk using mouse models using liquid handling pipettes from INTEGRA Biosciences. buff.ly/wtWyEC7
Streamlining genotyping workflows for muscle-bone research
buff.ly
November 17, 2026 at 6:13 PM
Dr Jean Kok, a postdoctoral researcher in the Robling Lab at Indiana University School of Medicine is investigating the molecular mechanisms underpinning muscle–bone crosstalk using mouse models using liquid handling pipettes from INTEGRA Biosciences. buff.ly/wtWyEC7
Streamlining genotyping workflows for muscle-bone research
www.labroots.com
November 17, 2026 at 6:13 PM
Dr Jean Kok, a postdoctoral researcher in the Robling Lab at Indiana University School of Medicine is investigating the molecular mechanisms underpinning muscle–bone crosstalk using mouse models using liquid handling pipettes from INTEGRA Biosciences. buff.ly/wtWyEC7
Streamlining genotyping workflows for muscle-bone research
buff.ly
November 17, 2026 at 6:13 PM
Dr Jean Kok, a postdoctoral researcher in the Robling Lab at Indiana University School of Medicine is investigating the molecular mechanisms underpinning muscle–bone crosstalk using mouse models using liquid handling pipettes from INTEGRA Biosciences. buff.ly/wtWyEC7
Streamlining genotyping workflows for muscle-bone research
www.labroots.com
November 17, 2026 at 6:13 PM
Dr Jean Kok, a postdoctoral researcher in the Robling Lab at Indiana University School of Medicine is investigating the molecular mechanisms underpinning muscle–bone crosstalk using mouse models using liquid handling pipettes from INTEGRA Biosciences. buff.ly/wtWyEC7
Streamlining genotyping workflows for muscle-bone research
buff.ly
November 17, 2026 at 6:13 PM
Dr Jean Kok, a postdoctoral researcher in the Robling Lab at Indiana University School of Medicine is investigating the molecular mechanisms underpinning muscle–bone crosstalk using mouse models using liquid handling pipettes from INTEGRA Biosciences. buff.ly/wtWyEC7
Streamlining genotyping workflows for muscle-bone research
buff.ly
November 17, 2026 at 6:13 PM
BIOER HPV Genotyping Real-Time PCR Kit (Fluorescent PCR) — Estimated US$633.6 / 48T

HPV Genotyping Real-Time PCR Kit is an in vitro diagnostic test for the qualitative detection of nucleic acid of Human Papillomavirus (HPV)type 6, 11, 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66 and 68…
BIOER HPV Genotyping Real-Time PCR Kit (Fluorescent PCR) — Estimated US$633.6 / 48T
HPV Genotyping Real-Time PCR Kit is an in vitro diagnostic test for the qualitative detection of nucleic acid of Human Papillomavirus (HPV)type 6, 11, 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66 and 68 in specimens of cervical swab.Estimated equipment price only. Shipping, import duties, installation, and logistics are additional and vary by destination and shipping method. We will contact you to confirm the total cost before processing your order.
scientificchina.com
November 14, 2026 at 5:43 AM
Successful predictive modeling of pollen fitness phenotypes is enabled by measures of expression specificity (Sebastian A F Mueller , Zuzana Vejlupkova , Molly Megraw , John E Fowler) doi.org/10.1093/plce... #PlantScience @aspbofficial @sebastian--mueller @jefowlerjr
Successful predictive modeling of pollen fitness phenotypes is enabled by measures of expression specificity
Abstract. The ability to predict phenotypes from genotypes in multicellular organisms remains limited despite rapid advances in genotyping and phenotyping
doi.org
November 11, 2026 at 1:29 PM
In France, 1,025 stools yielded 748 MLVA profiles, identifying 455 types vs 53 by gp60. MLVA better discriminated clusters; 5 clusters (>10 cases each) had probable foodborne origins.
Evaluation of the Systematic Use of Multilocus Variable Number Tandem Repeat Analysis in Comparison With gp60 Genotyping to Detect Cryptosporidium parvum Clusters
Many cryptosporidiosis outbreaks of various origins have been reported in recent years. In 2010, Cryptosporidium was responsible for 8.6 million cases and 3759 deaths of foodborne origin worldwide. The aim of this study was to compare a multilocus variable number tandem repeat analysis (MLVA) scheme and standard gp60 genotyping to detect clusters of Cryptosporidium parvum.MethodsWe compared the performance of an MLVA scheme and that of gp60 genotyping to detect C parvum clusters in France. During a 2-year period, stool samples received at the coordinating center of the French National Reference Centre for Cryptosporidiosis, Microsporidia and Other Digestive Protozoa were systematically analyzed via the MLVA scheme and gp60 genotyping.ResultsA total of 1025 stools were analyzed, leading to 748 fully interpretable MLVA profiles on C parvum isolates. We identified 53 genotypes using gp60 and 455 MLVA profiles. Based on the investigation of >10 cases with the same MLVA profile, 5 clusters were investigated; probable foodborne origins were identified. MLVA showed higher discrimination than gp60, facilitating the investigation of clusters, but gp60 remained useful. Alerts notifying health authorities of potential outbreaks should be based on threshold values for MLVA.ConclusionsMLVA could facilitate the detection and investigation of C parvum clusters. Further gp60 sequencing is still required. Defining appropriate alert thresholds could improve surveillance, outbreak investigation, and prevention strategies for public health.
academic.oup.com
November 13, 2026 at 2:00 PM
BIOER HPV Nucleic Acid Detection and 16/18 Genotyping Kit (Fluorescent PCR) — Estimated US$633.6 / 48T

This kit is used for in vitro qualitative detection of high-risk human papillomavirus (HPV) nucleic acid DNA in female cervical epithelial cell samples.Estimated equipment price only. Shipping,…
BIOER HPV Nucleic Acid Detection and 16/18 Genotyping Kit (Fluorescent PCR) — Estimated US$633.6 / 48T
This kit is used for in vitro qualitative detection of high-risk human papillomavirus (HPV) nucleic acid DNA in female cervical epithelial cell samples.Estimated equipment price only. Shipping, import duties, installation, and logistics are additional and vary by destination and shipping method. We will contact you to confirm the total cost before processing your order.
scientificchina.com
November 14, 2026 at 5:45 AM
A Friday the 13th genomics horror story:

A 2010 Science paper found variants tied to living past 100. The New York Times covered it.

A year later it was retracted. Data from different genotyping platforms were combined without accounting for them. Artifacts became "biology."
November 13, 2026 at 2:00 PM
At the AMP annual meeting, Roche emphasized the increasing importance of HLA genotyping for clinical trial enrollment and treatment selection.
Roche Adds HLA Typing to CGP Assay, Anticipating Growing Utility in Cancer Treatment Selection
Roche Adds HLA Typing to CGP Assay, Anticipating Growing Utility in Cancer Treatment Selection
ebx.sh
November 13, 2026 at 4:14 AM
Rapid HRM-Based Genotyping of Markers Associated with Yield and Fusarium Resistance in Maize https://doi.org/10.3390/ijms272210069 #Polymorphism
November 10, 2026 at 5:36 PM
Plasmodium vivax relapse reservoirs in Ethiopia: microhaplotype sequencing informs recurrent infection origins bioRxivpreprint
Plasmodium vivax relapse reservoirs in Ethiopia: microhaplotype sequencing informs recurrent infection origins
Determining the origin of recurrent Plasmodium vivax infections is critical for quantifying the public health burden of the hypnozoite reservoir, understanding transmission potential, and evaluating anti-relapse antimalarial efficacy. In Ethiopia, P. vivax is a major contributor to malaria burden, but the relative contribution of relapse to recurrent infections remains poorly quantified. We performed microhaplotype genotyping using a panel of 93 genome-wide markers and applied a probabilistic recurrence classification framework to recurrent P. vivax samples collected in two Ethiopian radical cure trials (IMPROV and OPRA). Genotyping was conducted on parasite isolates collected at enrolment and subsequent recurrences, with participants monitored over a 12-month follow-up period (IMPROV: 604 samples from 444 participants; OPRA: 621 samples from 342 participants). Recurrent infections were classified using a Bayesian hierarchical model implemented in Pv3Rs, which estimated marginal posterior probabilities of relapse, reinfection, or recrudescence based on genotyping data and background population dynamics. Priors were structured across biologically motivated time windows reflecting the natural history of P. vivax infection in Ethiopia and anticipated drug efficacy. Recurrences with a probability of relapse (p(L)) [≥] 0.75 were classified as relapses. In the absence of primaquine, probable relapse was the dominant classification for primary recurrent infections in both trials (75.5%; 102/135) and for consecutive recurrent infections within individuals (75.2%; 204/271). Primaquine substantially reduced the proportion of participants experiencing recurrent infections attributable to probable relapse, from 57.3% to 1.7% in IMPROV and from 60.2% to 9.5% in OPRA. Polyclonal infection at enrolment was independently associated with increased odds of recurrence and a higher rate of probable relapse in OPRA, with a consistent but non-significant trend observed in IMPROV. These findings provide direct molecular evidence that the hypnozoite reservoir is the dominant driver of recurrent P. vivax infections in Ethiopia in the absence of radical cure. The marked reduction in probable relapse following primaquine treatment highlights the critical importance of expanding access to safe and effective radical cure strategies in Ethiopia and other comparable high-transmission settings.
dlvr.it
November 15, 2026 at 12:44 AM
Great overview of the limitation of current avian influenza genotyping tools, clearly illustrating that approaches based on genetic simliarity have shortcomings and may be grouping viruses with distinct evolutoinary history together, erroneously.
👉 www.biorxiv.org/content/10.6...
November 9, 2026 at 1:07 AM
Great work on getting some light on the stench that is our public research funding system. Ngā mihi nui @mehr.nz

They have screwed the whole thing starting from their premise. Now we see that they can't answer the simple questions and are not tracking important indicators. 🤬
November 10, 2026 at 2:59 AM
Integrated genotyping, annotation and epigenetic characterization of transposable elements with GraffiTE https://www.biorxiv.org/content/10.64898/2026.11.06.764993v1
November 9, 2026 at 9:46 PM